Travel grant Switzerland, Swiss Nordic Bio on October 1, 2026

Important results from the project

Yes, the main objective of the project was achieved. The participation increased the visibility of Serial X and created new relevant contacts within the European life science ecosystem. Meetings and discussions also provided valuable feedback on the company´s investment case, market positioning and international growth strategy. Several of the contacts will be followed up with potential to contribute to Serial X´s ongoing capital raising, future partnerships and international expansion.

Expected long term effects

In the longer term, the results are expected to strengthen Serial X’s ability to attract international investment and support the company’s ongoing capital raise. The new investor and industry contacts may also lead to strategic partnerships, commercial opportunities and access to new European markets. Increased visibility within the European life science ecosystem can ultimately support the company’s commercialization, scaling and development.

Approach and implementation

The project was implemented according to plan by participating in Swiss Nordic Bio in Zurich. Prior to the conference, Serial X´s investor presentation was prepared and relevant investor and partner contacts were identified. During the conference, VD Yanyan Chen pitched Serial X, participated in individual meetings with investors and potential partners, and conducted active networking.

External links

Swiss Nordic bio 2026 conference